Immune regulation of myeloma cells

Research output: Contribution to journalArticle

Abstract

MM is a B-cell neoplasm that is accompanied by a variety of qualitative and quantitative alterations in immunoregulatory cells. Interactions between myeloma cells and immunoregulatory cells may relate both to disease progression and to some of the complications of MM, including hypogammaglobulinemia. Of particular interest is the relationship between stable-phase or plateau-phase myeloma and increased numbers of T-suppressor cells. In addition, the more recent discovery of production of certain interleukins and the presence of interleukin receptors on the plasma membranes of myeloma cells suggest that these cytokines may be involved in oncogenesis in MM. Because these cytokines may also be produced by immunoregulatory cells, further work needs to be done to determine the relative contribution of cytokines to the growth and regulation of myeloma cells. Finally, it is also possible that certain interleukins may be efficacious in the treatment of patients with MM.

Original languageEnglish (US)
Pages (from-to)79-82
Number of pages4
JournalClinical Immunology Newsletter
Volume10
Issue number6
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Interleukins
Cytokines
Interleukin Receptors
Agammaglobulinemia
Disease Progression
Carcinogenesis
B-Lymphocytes
Cell Membrane
Growth
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Immune regulation of myeloma cells. / Kay, Neil Elliot.

In: Clinical Immunology Newsletter, Vol. 10, No. 6, 1990, p. 79-82.

Research output: Contribution to journalArticle

@article{374b1bff93844027a6bb09237ff50ac8,
title = "Immune regulation of myeloma cells",
abstract = "MM is a B-cell neoplasm that is accompanied by a variety of qualitative and quantitative alterations in immunoregulatory cells. Interactions between myeloma cells and immunoregulatory cells may relate both to disease progression and to some of the complications of MM, including hypogammaglobulinemia. Of particular interest is the relationship between stable-phase or plateau-phase myeloma and increased numbers of T-suppressor cells. In addition, the more recent discovery of production of certain interleukins and the presence of interleukin receptors on the plasma membranes of myeloma cells suggest that these cytokines may be involved in oncogenesis in MM. Because these cytokines may also be produced by immunoregulatory cells, further work needs to be done to determine the relative contribution of cytokines to the growth and regulation of myeloma cells. Finally, it is also possible that certain interleukins may be efficacious in the treatment of patients with MM.",
author = "Kay, {Neil Elliot}",
year = "1990",
doi = "10.1016/0197-1859(90)90025-4",
language = "English (US)",
volume = "10",
pages = "79--82",
journal = "Clinical Immunology Newsletter",
issn = "0197-1859",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Immune regulation of myeloma cells

AU - Kay, Neil Elliot

PY - 1990

Y1 - 1990

N2 - MM is a B-cell neoplasm that is accompanied by a variety of qualitative and quantitative alterations in immunoregulatory cells. Interactions between myeloma cells and immunoregulatory cells may relate both to disease progression and to some of the complications of MM, including hypogammaglobulinemia. Of particular interest is the relationship between stable-phase or plateau-phase myeloma and increased numbers of T-suppressor cells. In addition, the more recent discovery of production of certain interleukins and the presence of interleukin receptors on the plasma membranes of myeloma cells suggest that these cytokines may be involved in oncogenesis in MM. Because these cytokines may also be produced by immunoregulatory cells, further work needs to be done to determine the relative contribution of cytokines to the growth and regulation of myeloma cells. Finally, it is also possible that certain interleukins may be efficacious in the treatment of patients with MM.

AB - MM is a B-cell neoplasm that is accompanied by a variety of qualitative and quantitative alterations in immunoregulatory cells. Interactions between myeloma cells and immunoregulatory cells may relate both to disease progression and to some of the complications of MM, including hypogammaglobulinemia. Of particular interest is the relationship between stable-phase or plateau-phase myeloma and increased numbers of T-suppressor cells. In addition, the more recent discovery of production of certain interleukins and the presence of interleukin receptors on the plasma membranes of myeloma cells suggest that these cytokines may be involved in oncogenesis in MM. Because these cytokines may also be produced by immunoregulatory cells, further work needs to be done to determine the relative contribution of cytokines to the growth and regulation of myeloma cells. Finally, it is also possible that certain interleukins may be efficacious in the treatment of patients with MM.

UR - http://www.scopus.com/inward/record.url?scp=45149138105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45149138105&partnerID=8YFLogxK

U2 - 10.1016/0197-1859(90)90025-4

DO - 10.1016/0197-1859(90)90025-4

M3 - Article

VL - 10

SP - 79

EP - 82

JO - Clinical Immunology Newsletter

JF - Clinical Immunology Newsletter

SN - 0197-1859

IS - 6

ER -